Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters
Since the emergence of the first omicron SARS-CoV-2 variant at the end of 2021, several sub-variants have evolved and become predominant in the human population, showing enhanced transmissibility and ability to (partly) escape the adaptive immune response. The XBB sub-variants (e.g., EG.5.1) have be...
Main Authors: | Rana Abdelnabi, Ria Lassaunière, Piet Maes, Birgit Weynand, Johan Neyts |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/1/122 |
Similar Items
-
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
by: Caroline S. Foo, et al.
Published: (2022-03-01) -
Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
by: Rana Abdelnabi, et al.
Published: (2022-12-01) -
Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19
by: Joran Degryse, et al.
Published: (2024-12-01) -
Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters
by: Melanie Rissmann, et al.
Published: (2022-12-01) -
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
by: Sreelekshmy Mohandas, et al.
Published: (2022-05-01)